IBD Management: State of the Art in 2018

Target Audience

This CME monograph will target gastroenterologists, primary care physicians, nurse practitioners, physician assistants, and nurses.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Personalize treatment plans for patients based on risk of aggressive disease

Describe strategies for managing loss of response to biologic therapies in patients with IBD

Position and incorporate newer therapies effectively into clinical practice

Differentiate among various oral and IV iron formulations for the treatment of anemia

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and The Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and The Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credit Designation

Purdue University Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This program has been approved for 1.25 contact hours.

Release Date: November 1, 2018Expiration Date: November 1, 2019  EXPIRED

Physician Disclosure Statement

All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, staff and reviewers of Gi Health Foundation and Purdue University College of Pharmacy have no relationships to disclose.

This activity is supported by educational grants from American Regent, Inc., Celgene Corporation, Janssen Biotech, Inc., Pfizer Inc. and Takeda Pharmaceuticals U.S.A., Inc.